Condition
Nontuberculous Mycobacterial Lung Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Nontuberculous Mycobacterial Lung Disease clinical trials that are recruiting, at sites in 4 countries (most in Taiwan (2), United States (2), Canada (1)). By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Nontuberculous Mycobacterial Lung Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Hypertonic saline inhalation for NTM lung disease | — | Taipei | Recruiting | Jun 15, 2026 |
| Biomarkers linked to response to phage treatment for nontuberculous mycobacterial and other infections | — | New York, New York | Recruiting | Jul 22, 2025 |
| Biomarker test using soluble PD-1 to predict progression in nodular-bronchiectatic NTM lung disease | — | Taipei | Recruiting | Jan 10, 2023 |
| Using Hypertonic Saline Inhalation to Treat Mycobacterium Avium Complex Lung Disease | Phase 4 | Nijmegen | Recruiting | Jan 14, 2022 |
| Using hypertonic saline to improve lung health in patients with M. avium complex infections | Phase 4 | New York, New York and 2 other locations | Recruiting | Jun 10, 2021 |
All recruiting trials (5)
-
Hypertonic saline inhalation for NTM lung disease
This trial tests whether starting inhaled 3% hypertonic saline early helps people with non-tuberculous mycobacterial lung disease feel better and clear bacteria better, compared with starting with normal saline first.
-
Biomarkers linked to response to phage treatment for nontuberculous mycobacterial and other infections
This project will test whether blood and airway biomarkers can show which adults with refractory nontuberculous mycobacterial or other bacterial infections respond to bacteriophage treatment.
-
Biomarker test using soluble PD-1 to predict progression in nodular-bronchiectatic NTM lung disease
This study tests whether levels of soluble PD-1 in blood can predict how quickly nodular-bronchiectatic NTM lung disease will progress.
-
Using Hypertonic Saline Inhalation to Treat Mycobacterium Avium Complex Lung Disease
This study tests if inhaling Hypertonic Saline along with regular care can help people with Mycobacterium avium complex lung disease feel better and improve their quality of life.
-
Using hypertonic saline to improve lung health in patients with M. avium complex infections
This study is testing if inhaling hypertonic saline can help people with lung infections from the M. avium complex feel better and clear the infection more effectively than standard care.
Related topics
Quick answers
How many Nontuberculous Mycobacterial Lung Disease clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Taiwan (2 trials), United States (2 trials), Canada (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.